Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05343663
Other study ID # B.30.2.ATA.. 0.01.00/553
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date December 1, 2022

Study information

Verified date April 2022
Source Ataturk University
Contact BAHAR Çiftçi
Phone 05068517857
Email bahar.ciftci@atauni.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research; The aim of this study is to examine the effects of self-management support given by tele-nursing for hypertension patients on patients' adherence to treatment and disease, self-efficacy level, self-care management and satisfaction level. This research is a randomized controlled and pretest-posttest applied design. The research will be carried out in Van Yüzüncü Yıl University Research Hospital with patients previously diagnosed with hypertension. The population of the research will consist of patients who have previously applied to the hospital where the research will be conducted and who have been diagnosed with hypertension who meet the research criteria. After the power analysis, it is planned to include 150 hypertension patients in the sample of the study. All patients in the intervention and control groups who meet the inclusion criteria will be verbally informed about the purpose of the study and the method of application, and their consent will be obtained. The pretest forms required for the research will be filled in by face-to-face interview method for all patients. In the study, the number of individuals in the randomization group will be determined by using the computer program, provided that they are equal in number. All materials prepared for self-management support will be delivered to the patients in the intervention group and they will be taught how to use them by the demonstration method. Patients will be asked to do the same procedure and the process will continue until they ensure correct use. Participants will be informed that there is a phone number that they can call whenever they want, when there are subjects that are not understood or that need to be repeated. Patients will be called three times a week and necessary checks will be made on blood pressure monitoring, nutrition, weight control, etc. In this way, patients in the intervention group will be followed remotely by tele-nursing for 3 months, their questions will be answered when they encounter problems, and guidance will be given in case of emergency. No intervention will be made in the control group. Necessary forms will be re-administered to all patients in both groups after 3 months as a post-test. At the end of the research, a comparison of the intervention and control groups will be made.


Description:

Type of research This project is a randomized controlled and pretest-posttest applied design. Location and Characteristics of the Research The research will be carried out in Van SBU Training and Research Hospital Research Hospital with patients who have been diagnosed with hypertension before. The number of cardiology outpatient clinics of Van Training and Research Hospital is 5. In our hospital, there are cardiology and internal departments that also include hypertension patients. There are 70 patients per day per cardiology outpatient clinic. The majority of them are individuals with hypertension and hypertension, as well as additional chronic diseases. It is questioned whether individuals follow their weight, whether they change their eating and drinking habits, whether they use their medications regularly, and finally whether they follow their blood pressure regularly. After this questioning, examination and various tests (blood analysis, ultrasound, etc.), the medicines of the patients are regulated. In general, patients are called for control every 2 months. However, this period is extended for individuals who take the warnings into account, measure their blood pressure regularly and see that it is stable at the expected level. Research Population and Sample Selection The population of the research will consist of patients who have previously applied to the hospital where the research will be conducted and who have been diagnosed with hypertension who meet the research criteria. The sample was calculated using the Hill-Bone Hypertension Treatment Adherence Scale, which was used in 2 studies. In order to determine the sample size, a priori power analysis was performed and it was determined that at least 55 hypertension patients were required for each of the intervention and control groups in order for the power of the study to exceed 80% at the 95% confidence interval, 0.05 significance level and medium effect size. In case of data loss, a total of 150 data will be collected by including 10% backup sample to this number. After the posttest data are collected, the power analysis will be looked at again. In the final power analysis, this rate is expected to exceed 90%. Data Collection All patients in the intervention and control groups who meet the inclusion criteria will be verbally informed about the purpose of the study and the method of application. "Informed Consent Form" will be filled in for the patients who agree to participate in the study. Then, the pre-test forms will be filled in by face-to-face interview method for all patients in the intervention and control groups. In the study, "stratification and block randomization methods" will be used in assigning participants to control and intervention groups. In the literature, it has been reported that age, gender and educational status are among the factors affecting drug and disease compliance, self-efficacy and self-management of hypertension patients. In line with this information, "age, gender and educational status" variables will be used in the stratification of hypertension patients in the study. Accordingly, patients will be stratified as "18-40, 41-60, 61 and above" for the age variable, "female and male" for the gender variable, "Primary School, Secondary School, High School and above" for the educational status variable, and randomization with blocks will be applied. In addition, 75 hypertension patients will be included in each of the study groups by ensuring that the layers are repeated five times in the study (2X2X2X5). Enterprise Group; All materials prepared for Self-Management Support will be delivered to the patients and they will be taught how to use them by the demonstration method. Patients will be asked to do the same procedure and will continue to be taught until they use it correctly. Participants will be informed that there is a phone number that they can call whenever they want, when there are subjects that are not understood or that need to be repeated. Phone; All patients will be registered on the telephone line to be used by the researchers and the telephone will be used only for research. The phone will be available at the cardiology nurse Sümeyra Autonomous. When the cardiology nurse Sümeyra Özerk could not be reached, so that the patients are not victims and that they can reach the phone whenever they want, the project coordinator Dr. Instructor A phone call will be made to member Bahar Çiftçi. At the same time, a group with the entire project team will be established and the arrangements for the project will be discussed there. Management of hypertension, ability to measure blood pressure at home, edema control, nutrition, movement, salt restriction, etc. Self-management support will be provided by providing training to teach. Patients will be called three times a week and necessary controls will be provided on training, blood pressure monitoring, nutrition, weight control, etc. It will be required to measure and record blood pressure twice a day with a digital and easy-to-use sphygmomanometer. In addition, it will be reminded that height-weight, blood pressure should be measured and recorded. It will be ensured that the materials sent to the patients are used in the measurement of height, weight and blood pressure. Patients will be reminded that they need to take measurements twice a day, and they will be warned to call the phone number that they can reach in case of emergency if an abnormal situation is encountered. In this way, patients in the intervention group will be followed remotely by tele-nursing for 3 months, their questions will be answered when they encounter problems, and guidance will be given in case of emergency. The content of the videos will be the same as the Training Booklet. The videos are planned to be between 3-5 minutes. It is planned to have videos that are explained in simple language that patients can understand. In addition, the videos will be presented to the patient after review. In the inclusion criteria of the research, "Computer/tablet/smartphone etc. to watch the videos. The videos can be watched comfortably, as it is a requirement to have "technological tools". Patients in the intervention group will be able to access the videos whenever they want. The videos will be shared only with the patients in the intervention group throughout the research. When the data collection phase is over, the videos will be shared first with the control group and then on the social media platform that hypertension patients can access. Evaluation of data The data will be evaluated in the SPSS (Statistical Package for Social Sciences for Windows, Version 22.0) package program. In the evaluation of the data, the statistical significance value will be accepted as 0.05, the Type 1 error will be kept at 5% and the evaluation will be made with a 95% confidence interval.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date December 1, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 72 Years
Eligibility Inclusion Criteria: - Follow-up for at least 6 months with the diagnosis of essential hypertension, - Using antihypertensive drugs, - No change in antihypertensive drug treatment in the last 1 month, - Not having any other accompanying chronic disease (Diabetes mellitus, cancer, chronic kidney failure, chronic obstructive pulmonary disease, heart failure, etc.), - Having no mental or communication problems, - Computer/tablet/smartphone etc. to watch videos. having technological tools, - Having internet, - Being over 40 years old, - Having at least primary education level, - Not being pregnant or lactating, Exclusion Criteria: - Follow-up for less than 6 months with the diagnosis of essential hypertension, - Not using antihypertensive drugs, - Changes in antihypertensive drug therapy in the last 1 month, - Presence of another concomitant chronic disease (Diabetes mellitus, cancer, chronic kidney failure, chronic obstructive pulmonary disease, heart failure, etc.), - Having a mental or communication problem, - Computer/tablet/smartphone etc. to watch videos. lack of technological tools, - Lack of internet, - Being under the age of 18, - Being illiterate - Being pregnant or breastfeeding,

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Education
Self-Management Program Conducted with Tele-Nursing will increase Treatment/Disease Adaptation, Self-Efficacy, Self-Care Management in Hypertension Patients.

Locations

Country Name City State
Turkey Atatürk University Faculty of Nursing Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hill-Bone Hypertension Treatment Adherence Scale (HBHTUS) The scale consists of 14 questions. On a four-point Likert scale (0=never, 1=sometimes, 2=often, and 3=always), interview (6, 7, and 8th items), medical (1, 2, 9, 10, 11, 12, 13) and 14. items) and nutrition (3, 4 and 5 items). Except for the 6th question of the scale, all of the other questions are in the form of negative questions. The total scores obtained from the scale range from 0 to 42, with a score of 0 indicating perfect adherence to treatment. A high total score from the scale indicates a decrease in adherence to treatment. 3months
Primary Self-Care Management Scale in Chronic Diseases (KHÖBYÖ) The scale consists of 35 items and is in a five-point Likert type (1 = strongly disagree, 2 = disagree, 3 = undecided, 4 = agree, 5 = strongly agree). Self-protection (items 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and social protection (1, 3, 4, 5, 7, 9, 10, 12) There are two sub-dimensions (items 13, 14, 16, 17, 21, 24 and 35). Items 3, 15, 19 and 28 in the scale are negative statements. The total scores that can be obtained from the scale vary between 35-175 points, and an increase in the score indicates that the individual's self-care management also increases. 3months
Primary Scale of Adjustment to Chronic Diseases (CHU) In the scale with three sub-dimensions and 25 items; physical adaptation, items 1, 9, 10, 13, 14, 15, 16, 18, 22, 23, 24 (maximum 55, minimum 11 points), social adaptation; Items 2, 3, 5, 7, 17, 19, and 25 (maximum 35, minimum 7 points), psychological adjustment; Items 4, 6, 8, 11, 12, 20, 21 (maximum 35, minimum 7 points) measure. The total score taken from the scale is 125. An increase in the scores obtained from the sub-dimensions and/or the whole scale means that the patients' level of compliance with the disease also increases. 3months
Primary The 6-item Self-Efficacy for Managing Chronic Diseases Scale(SEMCD6) It is an easy-to-use and effective tool for assessing the self-efficacy levels of patients with chronic diseases. The scale is rated on a 10-point scale ranging from "not at all sure" to "very sure". The score obtained from the scale is the average of 6 items, and high scores indicate high self-efficacy. If more than 1 answer is given to an item and the items are consecutive, the low score is included in the calculation. If the 2 answers given are not consecutive, this item is excluded from the calculation. In order for the scale to be calculated, at least 4 items must be answered. 3months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A